Clinical trials
Completed Phase 3 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
596 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 14 |
| 2001 | 28 |
| 2002 | 31 |
| 2003 | 26 |
| 2004 | 36 |
| 2005 | 25 |
| 2006 | 39 |
| 2007 | 28 |
| 2008 | 32 |
| 2009 | 32 |
| 2010 | 22 |
| 2011 | 22 |
| 2012 | 23 |
| 2013 | 28 |
| 2014 | 18 |
| 2015 | 19 |
| 2016 | 14 |
| 2017 | 14 |
| 2018 | 13 |
| 2019 | 16 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 4 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 596 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 41 |
| Novartis Pharmaceuticals | 29 |
| Alliance for Clinical Trials in Oncology | 26 |
| AstraZeneca | 17 |
| Pfizer | 15 |
| NSABP Foundation Inc | 13 |
| National Cancer Institute (NCI) | 13 |
| ETOP IBCSG Partners Foundation | 12 |
| SWOG Cancer Research Network | 12 |
| GBG Forschungs GmbH | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 596 |
| Neoplasm Metastasis | 26 |
| Neoplasms | 26 |
| Neutropenia | 17 |
| Hot Flashes | 14 |
| Prostatic Neoplasms | 13 |
| Breast Carcinoma In Situ | 11 |
| Multiple Myeloma | 11 |
| Osteoporosis | 11 |
| Breast Neoplasms, Male | 10 |
Trials
Showing 1 to 25 of 596. Each trial links to its page on Pharma Observatory.
496 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.